Eloxx Pharmaceuticals, Inc.
ELOX
$16.57
$0.402.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | 5,632.43% | -87.67% | -54.56% | -53.17% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -36.90% | -24.39% | 43.75% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -37.06% | -23.88% | -13.37% |
| Total Current Assets | -- | -- | -84.81% | -53.71% | -52.05% |
|
|
|||||
| Total Current Assets | -- | -- | -84.81% | -53.71% | -52.05% |
| Net Property, Plant & Equipment | -- | -- | -45.82% | -40.08% | -34.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -- | -- | -83.49% | -53.20% | -51.47% |
|
|
|||||
| Total Accounts Payable | -- | -- | -16.16% | 119.00% | -36.43% |
| Total Accrued Expenses | -- | -- | -51.85% | -33.29% | 73.04% |
| Short-term Debt | -- | -- | 16.90% | 236.69% | 228.31% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 240.49% | 614.16% | 383.96% |
| Total Finance Division Other Current Liabilities | -- | -- | -78.52% | -- | -- |
| Total Other Current Liabilities | -- | -- | -78.52% | -- | -- |
| Total Current Liabilities | -- | -- | 1.49% | 131.95% | 127.97% |
|
|
|||||
| Total Current Liabilities | -- | -- | 1.49% | 131.95% | 127.97% |
| Long-Term Debt | -- | -- | -66.77% | -28.67% | -17.19% |
| Short-term Debt | -- | -- | 16.90% | 236.69% | 228.31% |
| Capital Leases | -- | -- | -99.06% | -83.21% | -67.01% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -- | -- | -26.43% | 39.67% | 42.33% |
|
|
|||||
| Common Stock & APIC | -- | -- | 0.19% | 0.32% | 1.52% |
| Retained Earnings | -- | -- | -12.27% | -15.13% | -18.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -6.00% |
| Total Common Equity | -- | 68.84% | -239.42% | -147.62% | -115.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | 68.84% | -239.42% | -147.62% | -115.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | 68.84% | -239.42% | -147.62% | -115.10% |
|
|
|||||